Andrea Natale, MD

David O. Martin, MD, MPH
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Walid Saliba, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Patrick M. McCarthy, MD
Department of Thoracic and Cardiovascular Surgery, the Kaufman Center for Heart Failure, and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

A. Marc Gillinov, MD
Department of Thoracic and Cardiovascular Surgery, the Kaufman Center for Heart Failure, and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

William Belden, MD
Department of Cardiovascular Medicine and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

Nassir F. Marrouche, MD
Department of Cardiovascular Medicine and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

Andrea Natale, MD
Department of Cardiovascular Medicine and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Send to designated section author at: Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195.
Section I: David Martin, MD, Mail Code F15, martind3@ccf.org
Section II: Walid Saliba, MD, Mail Code F15, salibaw@ccf.org
Section III: Patrick McCarthy, MD, Mail Code F25, mccartp@ccf.org
Section IV: Andrea Natale, MD, Mail Code F15, natalea@ccf.org

Drs. Martin, Saliba, Belden, Marrouche, and Natale have indicated that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. McCarthy has indicated that he is a consultant to the AtriCure and Epicor Medical corporations.

Dr. Gillinov has indicated that he is a consultant to the AtriCure, Edwards Lifesciences, and Medtronic corporations.

David O. Martin, MD, MPH
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Walid Saliba, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Patrick M. McCarthy, MD
Department of Thoracic and Cardiovascular Surgery, the Kaufman Center for Heart Failure, and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

A. Marc Gillinov, MD
Department of Thoracic and Cardiovascular Surgery, the Kaufman Center for Heart Failure, and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

William Belden, MD
Department of Cardiovascular Medicine and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

Nassir F. Marrouche, MD
Department of Cardiovascular Medicine and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

Andrea Natale, MD
Department of Cardiovascular Medicine and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Send to designated section author at: Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195.
Section I: David Martin, MD, Mail Code F15, martind3@ccf.org
Section II: Walid Saliba, MD, Mail Code F15, salibaw@ccf.org
Section III: Patrick McCarthy, MD, Mail Code F25, mccartp@ccf.org
Section IV: Andrea Natale, MD, Mail Code F15, natalea@ccf.org

Drs. Martin, Saliba, Belden, Marrouche, and Natale have indicated that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. McCarthy has indicated that he is a consultant to the AtriCure and Epicor Medical corporations.

Dr. Gillinov has indicated that he is a consultant to the AtriCure, Edwards Lifesciences, and Medtronic corporations.

David O. Martin, MD, MPH
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Walid Saliba, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Patrick M. McCarthy, MD
Department of Thoracic and Cardiovascular Surgery, the Kaufman Center for Heart Failure, and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

A. Marc Gillinov, MD
Department of Thoracic and Cardiovascular Surgery, the Kaufman Center for Heart Failure, and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

William Belden, MD
Department of Cardiovascular Medicine and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

Nassir F. Marrouche, MD
Department of Cardiovascular Medicine and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

Andrea Natale, MD
Department of Cardiovascular Medicine and the Center for Atrial Fibrillation, The Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Send to designated section author at: Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195.
Section I: David Martin, MD, Mail Code F15, martind3@ccf.org
Section II: Walid Saliba, MD, Mail Code F15, salibaw@ccf.org
Section III: Patrick McCarthy, MD, Mail Code F25, mccartp@ccf.org
Section IV: Andrea Natale, MD, Mail Code F15, natalea@ccf.org

Drs. Martin, Saliba, Belden, Marrouche, and Natale have indicated that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. McCarthy has indicated that he is a consultant to the AtriCure and Epicor Medical corporations.

Dr. Gillinov has indicated that he is a consultant to the AtriCure, Edwards Lifesciences, and Medtronic corporations.

Andrea Natale, MD
Director, Electrophysiology Laboratories, Department of Cardiology, Cleveland Clinic

Address: Andrea Natale, MD, Department of Cardiology, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail natalea@ccf.org

Dr. Natale has indicated that he has received grant or research support from CPI and serves as a consultant for Cordis Webster Inc, and on the speakers' bureau for Knoll Pharmaceutical. He also has indicated that he is discussing therapies that are not yet FDA-approved for the use under discussion and products that are still investigational.

Andrea Natale, MD
Director, Electrophysiology Laboratories, Department of Cardiology, Cleveland Clinic

Address: Andrea Natale, MD, Department of Cardiology, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail natalea@ccf.org

Dr. Natale has indicated that he has received grant or research support from CPI and serves as a consultant for Cordis Webster Inc, and on the speakers' bureau for Knoll Pharmaceutical. He also has indicated that he is discussing therapies that are not yet FDA-approved for the use under discussion and products that are still investigational.

Andrea Natale, MD
Director, Electrophysiology Laboratories, Department of Cardiology, Cleveland Clinic

Address: Andrea Natale, MD, Department of Cardiology, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail natalea@ccf.org

Dr. Natale has indicated that he has received grant or research support from CPI and serves as a consultant for Cordis Webster Inc, and on the speakers' bureau for Knoll Pharmaceutical. He also has indicated that he is discussing therapies that are not yet FDA-approved for the use under discussion and products that are still investigational.